Clinical Trials
44 trialsProspective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
National Institutes of Health Clinical Center (CC)
DESCENT-1
A2 Biotherapeutics Inc.
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
National Institutes of Health Clinical Center (CC)
Rapid Autopsy and Procurement of Cancer Tissue
National Institutes of Health Clinical Center (CC)
iCaRe2
University of Nebraska
BASECAMP-1
A2 Biotherapeutics Inc.
TraveraRTGx
Travera Inc
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Molecular Analysis of Thoracic Malignancies
Stanford University
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
Imaging-Meso
Istituto Oncologico Veneto IRCCS
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
PARTNER
Azienda Ospedaliera di Padova
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
Mayo Clinic
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
ProgenaBiome
Staging Procedures to Diagnose Malignant Pleural Mesothelioma
Mayo Clinic
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
New Preclinical and Clinical Approaches to Mesothelioma
IRCCS Ospedale San Raffaele
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
Mayo Clinic
Studying the Clinical Trial Experiences of Patients With Mesothelioma
Power Life Sciences Inc.
Cardiac MRI Biomarker Testing (GCC 1618)
University of Maryland, Baltimore
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung
Sohag University
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma
Hospices Civils de Lyon
PSM
Oslo University Hospital
11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
Istituto Clinico Humanitas
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
National Institutes of Health Clinical Center (CC)
Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.
University of Liege
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
University Health Network, Toronto
CWM
Heart of England NHS Trust
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Ain Shams University
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Wake Forest University Health Sciences
Thrombin Generation and Platelet Activation in CRS/HIPEC
Ziekenhuis Oost-Limburg
MiCK Assay
Pierian Biosciences
Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Hospices Civils de Lyon
B-Receptor Signaling in Cardiomyopathy
Stanford University
CryoSpray Ablation(tm)Thoracic Patient Registry
CSA Medical, Inc.
Isolated Thoracic Perfusion (ITP-F) for MPM
Medias Klinikum for Surgical Oncology
Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Brigham and Women's Hospital
Serum Biomarkers in Diagnosis of Mesothelioma
Eskisehir Osmangazi University
Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
British Columbia Cancer Agency
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics